BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35954835)

  • 21. Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021.
    Gordon LG; Leung W; Johns R; McNoe B; Lindsay D; Merollini KMD; Elliott TM; Neale RE; Olsen CM; Pandeya N; Whiteman DC
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of intimate partner violence during pregnancy and postpartum to health services: a data linkage study in Queensland, Australia.
    Callander EJ; Bull C; Baird K; Branjerdporn G; Gillespie K; Creedy D
    Arch Womens Ment Health; 2021 Oct; 24(5):773-779. PubMed ID: 33856553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suicide crisis calls to emergency services: Cohort profile and findings from a data linkage study in Queensland, Australia.
    Meurk C; Wittenhagen L; Bosley E; Steele ML; Bunting D; Waterson E; Edwards B; Martain B; Heffernan E
    Aust N Z J Psychiatry; 2022 Feb; 56(2):144-153. PubMed ID: 33904321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The healthcare needs of preterm and extremely premature babies in Australia-assessing the long-term health service use and costs with a data linkage cohort study.
    Callander EJ; Atwell K
    Eur J Pediatr; 2021 Jul; 180(7):2229-2236. PubMed ID: 33693978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate.
    Nghiem S; Afoakwah C; Byrnes J; Scuffham P
    Heart Lung Circ; 2021 Aug; 30(8):1207-1212. PubMed ID: 33632592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do remote dialysis services really cost more? An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings.
    Gorham G; Howard K; Cunningham J; Barzi F; Lawton P; Cass A
    BMC Health Serv Res; 2021 Jun; 21(1):582. PubMed ID: 34140001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost impact of high staff turnover on primary care in remote Australia.
    Zhao Y; Russell DJ; Guthridge S; Ramjan M; Jones MP; Humphreys JS; Wakerman J
    Aust Health Rev; 2019 Jan; 43(6):689-695. PubMed ID: 30158049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
    Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
    Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care.
    Sharp L; Deady S; Gallagher P; Molcho M; Pearce A; Alforque Thomas A; Timmons A; Comber H
    BMC Cancer; 2014 Oct; 14():767. PubMed ID: 25319534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating inequities in cardiovascular care and outcomes for Queensland Aboriginal and Torres Strait Islander people: protocol for a hospital-based retrospective cohort data linkage project.
    Kearns T; Diaz A; Whop LJ; Moore SP; Condon JR; Andrews RM; Katzenellenbogen JM; Matthews V; Wang W; Johnston T; Taylor C; Potts B; Kathage A; Suleman A; Stanley L; Mitchell L; Garvey G; Williamson D
    BMJ Open; 2021 Mar; 11(3):e043304. PubMed ID: 33741666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase-specific and lifetime costs of cancer care in Ontario, Canada.
    de Oliveira C; Pataky R; Bremner KE; Rangrej J; Chan KK; Cheung WY; Hoch JS; Peacock S; Krahn MD
    BMC Cancer; 2016 Oct; 16(1):809. PubMed ID: 27756310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of screening for lung cancer in Australia.
    Marshall HM; Finn N; Bowman RV; Passmore LH; McCaul EM; Yang IA; Connelly L; Fong KM
    Intern Med J; 2019 Nov; 49(11):1392-1399. PubMed ID: 31336016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of cancer along the care continuum: What we can expect based on recent literature.
    Pisu M; Henrikson NB; Banegas MP; Yabroff KR
    Cancer; 2018 Nov; 124(21):4181-4191. PubMed ID: 30475400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital utilization, costs and mortality rates during the first 5 years of life: a population study of ART and non-ART singletons.
    Chambers GM; Lee E; Hoang VP; Hansen M; Bower C; Sullivan EA
    Hum Reprod; 2014 Mar; 29(3):601-10. PubMed ID: 24310618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coverage of cancer services in Australia and providers' views on service gaps: findings from a national cross-sectional survey.
    Hunter J; Smith C; Delaney GP; Templeman K; Grant S; Ussher JM
    BMC Cancer; 2019 Jun; 19(1):570. PubMed ID: 31185937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.
    Youlden DR; Baade PD
    BMC Cancer; 2011 Feb; 11():83. PubMed ID: 21342533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False economies in home-based parenteral antibiotic treatment: a health-economic case study of management of lower-limb cellulitis in Australia.
    Kameshwar K; Karahalios A; Janus E; Karunajeewa H
    J Antimicrob Chemother; 2016 Mar; 71(3):830-5. PubMed ID: 26702920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.